News

However, beneath this success lies a growing concern: the sustainability of this growth trajectory, particularly as ...
The market for drugs that encourage the immune system to attack tumors could explode in the next three years, leading Bristol ...
In the latest episode of The Top Line podcast, host Heath Clendenning interviews Cheryl Lubbert, CEO of Reverba Global, to ...
In a recent interview with Fierce, Brie Thomas, senior vice president of sales at Swoop, shared insights on the dramati | ...
A Philadelphia founder has been using artificial intelligence for life sciences materials since 2015, long before the mainstream hype for the tech.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
"Time" is launching an age-related initiative: "Time Longevity," which will feature reporting and analysis of the forces extending human life. Read the whole story ...
Aurobindo Pharma subsidiary CuraTeQ Biologics s.r.o. has received marketing authorisation for Zefylti, its filgrastim biosimilar version, from Medicines and Healthcare products Regulatory Agency ...
Pharmaceutical Executive: What makes this moment chaotic for Pharma marketers? Julius Ramirez: We’re at a moment of significant disruption across the healthcare and marketing landscape. Pharma ...
or they’re not able to access what pharma is doing in the way that’s convenient and seamless,” said Debra Harris, Ixlayer’s head of marketing. Digital solutions experts say pharma’s potential solution ...